Array BioPharma Inc. (ARRY)
Symbol Info
Listed Symbol ARRY
Name Array BioPharma Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-06-30
Latest Fiscal Revenue $56,537,000
Latest Fiscal EPS $-0.75
Price Info
21 Day Moving Average $46.7771
21 Day EMA $45.780100
50 Day Moving Average $38.8694
50 Day EMA $40.297850
200 Day EMA $27.465170
200 Day Moving Average 24.133600
52 Week High $47.98
52 Week Low $12.56
52 Week Change $221.788820
Alpha 0.049074
Beta 1.6370
Standard Deviation 0.222994
R2 0.064617
Periods 60
Share Information
10 Day Average Volume 6,159,104
20 Day Average Volume 5,236,457
30 Day Average Volume 9,637,183
50 Day Average Volume 7,397,452
Outstanding Shares 223,095,419
Float Shares 220,651,461
Percent Float 98.90%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 505
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 26,277,014
Institute Holdings Percent -
Institute Sold Previous 3 Months 60,076,965
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,443,958
Price Change
7 Day Price Change $1.0299988
7 Day Percent Change 2.20%
21 Day Price Change $1.0299988
21 Day Percent Change 2.20%
30 Day Price Change $1.5199966
30 Day Percent Change 3.28%
Month To Date Price Change $1.5200
Month To Date Percent 3.28%
90 Day Price Change $25.239998
90 Day Percent Change 111.63%
Quarter To Date $1.519997
Quarter To Date Percent 3.28%
180 Day Price Change $29.380000
180 Day Percent Change 159.07%
200 Day Price Change $30.140000
200 Day Percent Change 170.19%
Year To Date $33.600000
Year To Date Percent 235.79%
Profile
Description Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its clinical stage drugs include Binimetinib, Encorafenib, Selumetinib, Tucatinib/ONT-380, ARRY-382, LOXO-292 and LOXO-195 among others. The company has geographical presence in North America, Europe and Asia Pacific.
Details
Issue Type CS
Market Cap $10,675,115,799
Sec Type EQS
Auditor KPMG LLP
Total Shares Outstanding 223,095,419
CEO
Employees 298
Last Audit UQ
Classification
CIK 0001100412
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 3200 Walnut Street
Boulder, CO 80301
Website http://www.arraybiopharma.com
Facisimile
Telephone +1 303 381-6600
Email ir@arraybiopharma.com
Key Ratios
Profitability
EBIT Margin -47.4
EBITDA Margin -46.5
Pre-Tax Profit Margin -58.7
Profit Margin Cont -
Gross Margin 74.40
Profit Margin TOT -
Income Statements
Revenue $73,045,000
Revenue Per Share $0.3274
Revenue 3 Years $158.26
Revenue 5 Years $25.13
Valuation Measures
PE Ratio -
Enterprise Value $10,386,272,799
Price To Sales 146.166370
Price To Free Cash -120.1
PE High Last 5 Years -
Price To Book 35.4
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 35.4
Financial Strength
Total Debt To Equity 0.5
Int Coverage -11.2
Current Ratio 5.7
Leverage Ratio 2.0
Quick Ratio 5.2
Long Term Debt To Capital 0.31
Assets
Receivables Turnover 2.3
Invoice Turnover 27.90
Assets Turnover 0.10
Management Effectiveness
Return Assets -24.74
Return On Equity -46.44
Return On Capital -31.15
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ARRY
Array Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.